Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBT (2016 - 2026)

Exponent's EBT history spans 17 years, with the latest figure at -$103.0 million for Q1 2026.

  • For the quarter ending Q1 2026, EBT changed 0.07% year-over-year to -$103.0 million, compared with a TTM value of $10.2 million through Jan 2026, down 22.23%, and an annual FY2026 reading of $10.2 million, down 22.23% over the prior year.
  • EBT for Q1 2026 was -$103.0 million at Exponent, down from $38.6 million in the prior quarter.
  • The five-year high for EBT was $40.4 million in Q1 2024, with the low at -$103.0 million in Q1 2026.
  • Average EBT over 5 years is $18.2 million, with a median of $35.5 million recorded in 2022.
  • Year-over-year, EBT grew 13.75% in 2024 and then crashed 442.02% in 2025.
  • Tracing EXPO's EBT over 5 years: stood at $30.5 million in 2022, then dropped by 1.41% to $30.1 million in 2023, then rose by 19.44% to $35.9 million in 2024, then grew by 7.46% to $38.6 million in 2025, then tumbled by 366.66% to -$103.0 million in 2026.
  • Per Business Quant, the three most recent readings for EXPO's EBT are -$103.0 million (Q1 2026), $38.6 million (Q4 2025), and $36.8 million (Q3 2025).